Community Connect | Communities’ right to newer, safer, more effective regimens for drug-resistant TB

Wednesday, November 15, 3:30am - 4:30am (EST)

Time shown in-04:00 America, New York

Tuberculosis is an ancient epidemic that has marked the human experience throughout history. Despite affecting more than 10 million people every year and claiming approximately 1.6 million lives in 2021 alone - more than any other infectious disease - the progress in tuberculosis treatment has moved ahead at a glacial pace. This session will focus on the clinical trials and country roll outs of new treatments for drug-resistant TB, the activists pushing for the adoption of this new regimen, and the perspective of people affected by TB on the issue.

Find more information in the online program.

Add to Calendar 2023/11/15 09:30:00 2023/11/15 10:30:00 Europe/Paris Community Connect | Communities’ right to newer, safer, more effective regimens for drug-resistant TB Tuberculosis is an ancient epidemic that has marked the human experience throughout history. Despite affecting more than 10 million people every year and claiming approximately 1.6 million lives in 2021 alone - more than any other infectious disease - the progress in tuberculosis treatment has moved ahead at a glacial pace. This session will focus on the clinical trials and country roll outs of new treatments for drug-resistant TB, the activists pushing for the adoption of this new regimen, and the perspective of people affected by TB on the issue.

Find more information in the online program. Foyer Bleu Paris false MM/DD/YYYY 30 OPAQUE ambQfBYOGzRZxDTimmgh72967

Foyer Bleu Paris

TB Alliance at the Union Conference

Link: